Visits (weeks)
|
W-1
|
W0
|
W1
|
W2
|
W3
|
W4
|
W5
|
W6
|
W7
|
W8
|
W9
|
W10
|
W34
|
Informed consent
|
X
| | | | | | | | | | | | |
Eligibility screen
|
X
| | | | | | | | | | | | |
Randomization
|
X
| | | | | | | | | | | | |
Neuropsychological assessment 1
|
Cognitive complaint questionnaire
|
X
| | | | | | | | | | | | |
BCcogSEP
|
X
| | | | | | | | | | | | |
VAPS
|
X
| | | | | | | | | | | | |
Multiple errands test
|
X
| | | | | | | | | | | | |
Neuropsychological assessment 2
|
MUSIQOL
| |
X
| | | | | | | | | |
X
|
X
|
SEI
| |
X
| | | | | | | | | |
X
|
X
|
MADRS
| |
X
| | | | | | | | | |
X
|
X
|
HAMA
| |
X
| | | | | | | | | |
X
|
X
|
BICAMS = SDMT, CVLT-II, BVMT-R
| |
X
| | | | | | | | | |
X
|
X
|
MCQ-30
| |
X
| | | | | | | | | |
X
|
X
|
EMIF-SEP
| |
X
| | | | | | | | | |
X
|
X
|
PSQI
| |
X
| | | | | | | | | |
X
|
X
|
Active control group
|
At-home set-up
| | |
X
| | | | | | | | | | |
Phone follow-up
| | | |
X
|
X
|
X
| |
X
|
X
|
X
|
X
| | |
At-home follow-up
| | | | | | |
X
| | | | | | |
Experimental group with CR intervention
|
CR intervention
| | | |
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
| | |
At-home set-up
| | |
X
| | | | | | | | | | |
Phone follow-up
| | | |
X
|
X
|
X
| |
X
|
X
|
X
|
X
| | |
At-home follow-up
| | | | | | |
X
| | | | | | |